Pharmacological Treatment Of Cardiac Arrhythmia

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorSaien, Benjamin
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2020-02-24T11:08:38Z
dc.date.available2020-02-24T11:08:38Z
dc.date.created2019-05
dc.description.abstractThe aim of this thesis is to discuss the most commonly used drugs for the management of cardiac arrhythmias collectively known as antiarrhythmic agents. We will discuss the classifications of anti-arrhythmic drugs, indications, contraindications and adverse effects of administering antiarrhythmic drugs that may develop. The ultimate goal of antiarrhythmic drug therapy is to restore normal rhythm and conduction. When it is not possible to revert to normal sinus rhythm, drugs may be used to prevent more serious and possibly lethal arrhythmias from occurring. Antiarrhythmic drugs are used to decrease or increase conduction velocity, alter the excitability of cardiac cells by changing the duration of the effective refractory period suppress abnormal automaticity. All antiarrhythmic drugs directly or indirectly alter membrane ion conductance, which in turn alters the physical characteristics of cardiac action potentials. For example, some drugs are used to block fast sodium channels. These channels determine how fast the membrane depolarizes (phase 0) during an action potential. Since conduction velocity is related to how fast the membrane depolarizes, sodium channel blockers reduce conduction velocity.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent59hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/281209
dc.language.isoenhu_HU
dc.subjectCardiac Arrhythmiahu_HU
dc.subjectAnti Arrhythmic Agenthu_HU
dc.subjectVaughan Williamhu_HU
dc.subjectSicilian Gambithu_HU
dc.subjectArrhythmiashu_HU
dc.subjectSinoatrial Nodehu_HU
dc.subjectAtrioventricular Nodehu_HU
dc.subjectBundle Of Hishu_HU
dc.subjectPurkinje Fibershu_HU
dc.subjectAction Potentialshu_HU
dc.subjectSodium Channelhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titlePharmacological Treatment Of Cardiac Arrhythmiahu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)